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ABSTRACT 
 
INTRODUCTION: Alcohol withdrawal in older adults, despite being prevalent, 
is an understudied and thus poorly understood syndrome. The lack of 
evidence-based studies regarding presentation, diagnosis, treatment, and 
outcomes has led to poor recognition and often inadequate treatment of this 
syndrome in older adults. 
MANUSCRIPT 1: Alcohol Withdrawal in the Elderly: A Systematic Review 
OBJECTIVES: To identify the current evidence about alcohol withdrawal 
syndrome and treatment in older adults.  
METHODS: Using the guidelines of the Preferred Reporting Items for 
Systematic Reviews and Meta-analyses (PRISMA) statement, we conducted a 
systematic review of articles from 1/1/1980-6/1/2012. The search included 
several databases and used plain language key words such as “alcohol 
withdrawal,” “alcohol withdrawal syndrome,” “alcohol withdrawal seizures,” 
“alcohol withdrawal delirium,” “ethanol withdrawal,” and “alcoholism.”  Studies 
that included and/or focused on older adults were included. The details of the 
study design, participant characteristics, study setting, assessment, and 
outcome data were extracted from each of the included studies. 
RESULTS: Seven studies were identified and all were descriptive cohort 
studies; 3 prospective, 2 retrospective, and 3 retrospective and prospective.  
All studies included both younger and older adults. More severe withdrawal 
was reported in several, but not all, studies. Similar findings were seen with 
	  
	  
respect to duration of hospitalization, frequency of delirium tremens, and 
dosages of benzodiazepines.  
CONCLUSIONS: The literature regarding older adults and alcohol withdrawal 
is limited with only seven studies to date. The small pool of existing literature 
provides no consensus on how older adults manifest with and are treated for 
alcohol withdrawal.  
MANUSCRIPT II: Alcohol Withdrawal in the Elderly: A Descriptive Study 
OBJECTIVES: To describe the population of older adults with alcohol 
withdrawal who present to the Emergency Department (ED) and are admitted 
to the hospital.  
METHODS: We conducted a retrospective chart review of patients aged ≥ 65 
years who presented to the ED and were admitted and treated for alcohol 
withdrawal syndrome (AWS). Potential patients were identified using ICD-9 
codes for alcohol-induced mental disorders.  Patients were excluded if no 
alcohol withdrawal treatment was administered or the subject was directly 
admitted to the psychiatry service. Data regarding demographics, symptoms, 
treatments, and outcomes were collected.  
RESULTS: A total of 211 patients were screened and 90 (mean age 73 years, 
59% men) were given a diagnosis of AWS and are included in this analysis. 
The most common physical comorbidity reported was hypertension (16%) and 
coronary artery disease (19%); 16% had multiple (≥ 3) major physical 
comorbidity. The chief complaint was alcohol-related (48%), trauma (30%), 
followed by psychiatric conditions (13%); 13% were suicidal at presentation. 
Tremors were documented in 42% of cases, and were present for 32%.  
	  
	  
Hyperreflexia was not documented in 99% of cases.  Tongue fasciculations 
were documented in 13% and were present in 10%. In total, 59% received at 
least one dose of a benzodiazepine in the ED; specifically lorazepam (12%), 
diazepam (21%) or chlordizepoxide (4%); an additional 22% received a 
combination of these.  For 41%, no benzodiazepine was ordered in the ED. 
The standard Clinical Institute Withdrawal Assessment protocol was followed 
in 41%.  Based on post-discharge surveillance, 36 patients (25%) presented to 
the ED again within 30 days; of these 18 had alcohol-related conditions, 10 
had trauma, 3 had psychiatric conditions, and 14 had other diagnoses.   
CONCLUSIONS: Commonly held notions that elderly patients with AWS are 
more likely to have multiple comorbidities, live alone, and present with a 
traumatic or infectious complaints, are not universally correct.  ED physicians 
likely need to re-assess how they approach older adults, to raise their index of 
suspicion for alcohol withdrawal in this population, and to be more systematic 
and efficient in identifying older adults with AWS.  
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ABSTRACT 
OBJECTIVE: To identify the current existing evidence about alcohol 
withdrawal syndrome and treatment in older adults.  
METHODS: Using the guidelines of the Preferred Reporting Items for 
Systematic Reviews and Meta-analyses (PRISMA) statement, we conducted a 
systematic review from 1/1/1980-6/1/2012. The search included several 
databases and used plain language key words such as “alcohol withdrawal,” 
“alcohol withdrawal syndrome,” “alcohol withdrawal seizures,” “alcohol 
withdrawal delirium,” “ethanol withdrawal,” and “alcoholism.”  Studies that 
included and/or focused on older adults were included. The details of the 
study design, participant characteristics, study setting, assessment, and 
outcome data were extracted from each of the included studies. 
RESULTS: Seven studies were identified and all were descriptive cohort 
studies; 3 prospective, 2 retrospective, and 3 retrospective and prospective.  
All the studies included subjects of all ages, young and old. A more severe 
withdrawal syndrome in older adults was identified in several studies, but other 
found no difference. The same finding was seen with respect to duration of 
hospitalization, frequency of delirium tremens, and dosage of 
benzodiazepines.  
CONCLUSIONS: The literature regarding older adults and alcohol withdrawal 
is limited with only seven studies to date. Further, the small pool of existing 
literature provides no consensus on the details of how older adults manifest 
with and are treated for alcohol withdrawal.  
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INTRODUCTION 
Excessive chronic alcohol consumption among older adults is a common but 
under-recognized public health issue.1  Alcohol withdrawal syndrome (AWS), 
which may occur when a chronic user abruptly stops drinking alcohol, can 
have significant medical consequences.2,3 If not recognized and aggressively 
treated early in the disease process, AWS may progress swiftly to seizures, 
delirium tremens, autonomic instability, and even death.2,3 Most existing 
literature on AWS has focused on younger populations. AWS may have a 
more significant impact on older patients, who have less physiologic reserve, 
more medical co-morbidities, altered pharmacokinetics, increased CNS 
sensitivity to toxins, underlying cognitive deficits, longer duration of alcohol 
abuse, and greater susceptibility to medication-alcohol interactions.1,4  
A better understanding of AWS in older adults is critical to improve its 
recognition and tailor its treatment in order to optimize care of these 
particularly vulnerable patients. Our research goal was to systematically 
identify existing evidence about alcohol withdrawal syndrome and treatment in 
older adults.  
 
 
METHODS 
 
The guidelines from the Preferred Reporting Items for Systematic Reviews 
and Meta-analyses (PRISMA) statement were followed.5 
 
Protocol and Registration 
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Before conducting our review, we developed a comprehensive systematic 
review protocol in close consultation with a research librarian (DD).  We 
registered our protocol with the International Prospective Register of 
Systematic Reviews (PROSPERO).6  (It is available at: 
http://www.metaxis.com/prospero/full_doc.asp?RecordID=2581) 
 
Search Strategy 
We collaborated with a research librarian (DD) to develop a comprehensive 
search strategy.  We searched MEDLINE, EMBASEM CINAHL, PsycINFO, 
Cochrane, Alcohol and Alcohol Problems Science Database, and Information 
on Drugs and Alcohol from 1/1/1980-6/1/2012.  Our search employed the 
controlled vocabulary of each database and plain language and used: “alcohol 
withdrawal,” “alcohol withdrawal syndrome,” “alcohol withdrawal seizures,” 
“alcohol withdrawal delirium,” “ethanol withdrawal,” and “alcoholism.”  We 
employed filters to effectively limit our search to identify geriatric patients.7 The 
final search results were limited to human studies and English language 
studies using the limits provided within each database.  We also evaluated 
reference lists of reviews and retrieved articles to check for additional studies.  
Our search strategy was independently evaluated by a research librarian who 
was not a member of the research team, with any suggestions incorporated.   
 
Inclusion Criteria 
Inclusion criteria were: original research studies analyzing presentation, 
natural history, complications and/or treatments of alcohol withdrawal 
syndrome that (1) used age as an analytic factor AND (2) included at least 10 
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subjects aged > 55 OR at least 1 age category including only patients > 55 OR 
with age range including patients > 75.  
 
Data Collection and Processing 
Two study authors (MK, AK) independently and in duplicate screened and 
retrieved titles, abstracts, and full-text articles for inclusion using the pre-
designed protocol.  Those not meeting inclusion criteria were excluded based 
on the abstract, and full text of each potential article was obtained by each 
reviewer and evaluated.  Data was collected and stored in EndNote software 
(Philadelphia, PA).8 Disagreements about any study inclusions were resolved 
by consensus.  
 
Data Extraction and Analysis 
Details of the study design, participant characteristics, study setting, 
assessment, and outcome data were extracted from each of the included 
studies. Disagreements about extracted data were resolved by consensus. All 
studies were evaluated for potential confounding, measurement error, and 
selection bias.  While the initial protocol had allowed for consideration of meta-
analysis of results, this was abandoned given the small number of publications 
with varied methods that were obtained. 
 
 
RESULTS 
Search Results  
The initial search identified 5,069 citations after duplicates were removed. 
After review of these titles and abstracts, 247 full text articles were retrieved 
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and reviewed in detail. Seven of these met inclusion criteria. The remaining 
were excluded for various reasons including not being focused on the 
syndrome of alcohol withdrawal, not using age as an analytic factor, or not 
containing at least 10 subjects > 55 years of age in their study population. 
Details of our search results are shown in Figure 1.1. 
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Figure 1.1: PRISMA Diagram 
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Description of Studies   
A systematic review of 7 major electronic databases, including 3 that are 
solely focused on psychiatric, drug, and alcohol research, was conducted 
between the years 1/1/1980-6/1/2012 and revealed only 7 studies published 
between 1989 and 2001 that looked at alcohol withdrawal in the elderly 
population in some form. In addition to this low number of studies from which 
to draw conclusions, each study varied greatly with respect to the 
methodologies they employed. All were descriptive cohort studies; 3 
prospective, 2 retrospective, and 3 retrospective and prospective.  All the 
studies included subjects of all ages, young and old. None evaluated an 
intervention specifically directed at older withdrawal patients.  Studies used 
different age categories for analysis, with some stratifying by decade and 
others variously defining older adults as ≥58, ≥60, or ≥70. Both the countries in 
which the studies were conducted, as well as the specific clinical settings for 
the studies were variable, therefore resulting in study populations that were 
highly heterogeneous. While the majority of the studies were conducted in the 
United States (4), the three studies with the largest numbers of subjects were 
conducted in Australia, Poland, and Germany, respectively.9-11 The clinical 
setting of the studies revealed significant variation as well. Four were 
conducted at inpatient alcohol treatment facilities (community and academic 
centers), two in Internal Medicine inpatient service units (both academic 
centers), and one at an inpatient psychiatric unit of a psychiatric hospital. 
Interestingly, no studies were conducted in the Emergency Department, where 
the majority of alcohol withdrawal cases are likely to initially present. The age 
ranges for what was considered “geriatric” varied across many of the studies. 
Four studies used the same geriatric age definition of 60 years of age or 
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greater, however, the remaining 3 did not. For these remaining 3 studies, one 
used 58 years or greater, one used 70 years or greater, and one did not define 
an age cut off. Different scales were used to assess withdrawal symptoms. 
When evaluating alcohol withdrawal, several scales can be used. The Clinical 
Institute Withdrawal Assessment for Alcohol scale (CIWA), is a 10-item scale 
used in the assessment and management of alcohol withdrawal. Each item is 
scored independently and then a sum is calculated. The maximum score is 67; 
mild alcohol withdrawal is a score of 15 or less, moderate 16-20, and severe 
greater than 20. The ten items evaluated are: nausea/vomiting, tremor, 
paroxysmal sweats, anxiety, agitation, tactile disturbances, auditory 
disturbances, visual disturbances, headache, orientation and clouded 
sensorium.  The Alcohol Withdrawal Scale (AWS) is a modification of the 
CIWA. It is an 18-item scale and incorporates all of the items in the CIWA as 
well as items to measure level of benzodiazepine intoxication, which is seen 
frequently in patients being treated with benzodiazepines during the course of 
alcohol withdrawal. For our reviewed studies two used the CIWA scale, three 
used the AWS. The remaining studies used other assessment methods; one 
used criteria for the diagnosis of alcohol withdrawal as defined by the DSM III 
and one used no scale at all, opting instead to use a compilation of 17 
withdrawal signs and symptoms to do their assessment. Characteristics of the 
7 studies are described in detail in Table 1.1.  
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Table 1.1 Study Findings Summary 
 
Study Year & 
Country 
Study 
Design & 
Setting 
Ages & 
Sample 
Size 
Measures & 
Assessments 
Findings 
Liskow 
et al. 
1989 
USA 
Cohort 
Prospective 
Inpatient 
alcohol 
treatment 
units at 
Veterans 
Affairs 
Hospital 
Older 
subjects 
aged 58-77 
compared to 
younger 
subjects 
26 older 
subjects in 
analysis 
compared to 
24 younger 
subjects 
103 total 
study 
subjects 
- AWIS (Alcohol 
Withdrawal and 
Intoxication 
Scale  
 
- Dose of 
chlordiazepoxide 
given 
- duration of 
withdrawal 
- Had higher AWIS scores 
(mean on day 1: 22.3 vs. 12.2 
for younger subjects), 
suggesting an increased 
severity of withdrawal 
symptoms 
- had increased duration of 
withdrawal symptoms (mean 
AWIS score on day 5: 9.2 vs. 
6.7 for younger subjects) 
- Required larger doses of 
chlordiazepoxide for symptom 
control (mean total dose day 
1: 140.4mg vs 62.5mg for 
younger subjects, day 3: 85.5 
mg vs. 20.8 mg) 
Brower 
et al. 
1994 
USA 
Cohort 
Retrospective 
2 inpatient 
alcohol 
treatment 
programs 
(one 
specializing in 
treatment of 
older adults) 
at a 
community 
thospital 
Older 
subjects 
aged ≥60 
compared 
to:  
younger 
subjects 
aged 21-35 
48 older 
subjects in 
analysis 
compared 
to: 36 
younger 
subjects 
chart review for:  
- documentation 
of 17 withdrawal 
symptoms  
- treatment 
regimen 
- had increased number of 
withdrawal symptoms (mean 
total symptoms of 6.8 vs. 5.6 
for younger subjects) 
- had increased duration of 
symptoms (mean last day of 
symptoms 9.0 vs. 6.5 for 
younger patients) 
- had no significant difference 
in required medication dose  
- had no significant difference 
in duration of medication 
treatment 
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Ferguso
n et al. 
1996 
USA 
Cohort 
Retrospective 
Inpatient 
internal 
medicine 
service  
 
Subjects 
aged:  19-
78, mean 
41.9  
200 total 
study 
subjects 
chart review for:  
- documentation 
of withdrawal 
symptoms 
consistent with 
DSM III 
diagnosis of 
delirium tremens 
- DTs occurred with equal 
frequency among all age 
groups 
 
- oldest subject experiencing 
DTs was 70 years old 
Foy et 
al. 
1997 
Australia 
Cohort 
Prospective 
Inpatient 
internal 
medicine 
service 
Older 
subjects 
aged ≥70 
compared 
to:  
younger 
subjects 
aged <70 
55 older 
subjects in 
analysis  
compared 
to: 
484 younger 
subjects 
-AWS (Alcohol 
Withdrawal 
Scale) 
(modification of 
the CIWA-A, 
previously 
published by the 
authors, 1986) 
-dose of 
diazepam given 
Older adults: 
- had increased risk of 
complications (odds 
ratio=1.8) 
- had trend towards increased 
risk of delirium 
Kraemer 
et al. 
1997 
USA 
Cohort 
Retrospective 
and 
prospective 
Inpatient 
internal 
medicine 
service 
Older 
subjects 
aged ≥60 
compared 
to:  
younger 
subjects 
aged<60  
84 older 
subjects in 
analysis 
compared 
to: 
200 younger 
subjects 
- CIWA-Ar 
(Revised Clinical 
Institute for 
Alcohol 
Withdrawal 
Scale) scores 
- dose of 
benzodiazepine 
given 
- duration of 
withdrawal 
- development of 
complications  
Older adults (aged ≥60) 
- had increased risk of 
delirium (including but not 
limited to DTs) 
- had increased transient 
dependency in 2+ ADLs 
- had trend toward significant 
increase in witnessed falls 
- required more IV fluid 
administration  
- required use of restraints 
more frequently 
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Wetterlin
g et al. 
2001 
German
y 
cohort 
Prospective 
Inpatient 
alcohol 
treatment unit 
at an 
academic 
hospital 
3 age 
groups used 
for analysis:  
<30, 30-59, 
≥60 
41 subjects 
aged ≥60  
compared 
to: 
611 
subjects 
aged 30-59  
compared 
to: 
71 subjects 
aged <30 
AWS (Alcohol 
Withdrawal 
Syndrome)  
Older adults (aged ≥60): 
- had no significant difference 
in AWS scores 
- had no significant difference 
in duration of withdrawal 
(defined as AWS>3) 
 
- had more previous years of 
alcohol dependence 
- had trend towards more 
severe concomitant medical 
disorders 
- had trend towards less 
reported 
Wojnar 
et al. 
2001 
Poland 
Cohort 
Retrospective 
and 
prospective 
Inpatient 
general 
psychiatric 
hospital 
5 age 
groups: 
<30, 30-39. 
40-49, 50-
59, ≥60 
50 subjects 
aged ≥60  
compared 
to:192 
subjects 
aged 50-59  
compared 
to:394 
subjects 
aged 40-49  
compared 
to:437 
subjects 
aged 30-39  
compared 
to: 
140 
subjects 
aged <30 
-structured 
questionnaire 
completed by 
treating 
psychiatrists  
-CIWA-A scale 
(patients 
enrolled 
prospectively 
only, n=321) 
Older adults (aged ≥60, 
comparing 5 age groups): 
- had no significant difference 
in severity of withdrawal 
symptoms 
- had no significant difference 
in incidence of DTs  
- had a greater frequency of 
hypertension, hypokalemia, 
other complications of alcohol 
withdrawal 
- had no significant difference 
in duration of withdrawal 
- had longer duration of 
hospitalization (mean length 
of stay 11.5 days for subjects 
aged ≥60 vs. 8.8 days in 
subjects aged ≤40) despite 
resolution of withdrawal 
- had no significant difference 
in required medication dose  
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Findings from Studies 
Three studies found that adults ages >70, >58, and >60 respectively, 
had more severe withdrawal syndromes than younger patients as defined by 
one or more of the following: an increased number of withdrawal symptoms 
such as tachycardia, hypertension, tremor, and delirium, increased duration of 
symptoms, increased duration of hospitalization, higher doses of 
benzodiazepines required, higher CIWA or AWS scores overall.9,12,13 Two 
studies found no difference in withdrawal severity among the age groups.10,11  
Wojnar and Kraemer found that adults >60 years of age had a longer 
duration of hospitalization (11.5 days vs. 8.8 days and 5.9 days vs. 3.5 days 
respectively) for the treatment of their alcohol withdrawal10,14 Two studies 
found that adults >58 years of age and >60 years of age, respectively, had a 
longer duration of alcohol withdrawal symptoms as shown by higher AWIS 
scores with one showing AWIS scores of >6 on day 5 as compared to the 
younger cohort whose AWIS scores were <7 on day 5, and the other showing 
symptoms persisting at day 9 of hospitalization while the younger cohort had 
symptom resolution before day 7. 12,13 But two others found no difference.10,11   
Delirium tremens was found to be more common among older adults by 
Foy and Kraemer,9,14 but two others found no difference.10,15 Ferguson, 
Wetterling, and Wojnar all showed that regardless of the number of years of 
problem drinking or number of drinks in the most recent binge, adults >60 
years of age developed clinically significant delirium, as defined by AWS and 
CIWA scores, at the same rates as their younger heavy drinking cohorts.9-11 
Furthermore, Foy and Kraemer showed that, in fact, adults >70 and >60 years 
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of age, respectively, were at higher risk than their younger cohorts at 
developing clinically significant delirium.9,14  
The dosage of benzodiazepines needed for alcohol withdrawal 
treatment was also variable. Liskow observed that adults >58 years of age 
being treated for alcohol withdrawal required double and triple the amounts of 
Chlordiazepoxide (140.4mg vs. 62.5mg and 85.5mg vs. 20.8mg) for symptom 
control (tremors, sweating, nausea/vomiting, disorientation, hallucinations, 
delusions, agitation, tachycardia, seizures, ataxia, dysarthria, and nystagmus) 
on days 1 and 3, respectively.12 However, two other studies found no 
difference in the dosage requirements between the age groups.10,13  
Only Kraemer looked at restraint use and found that the use of 
restraints was more common in older adults (age > 60) with alcohol withdrawal 
as compared to younger adults (age < 60) with rates of 11.9% versus 2.5%, 
respectively. However, the type of restraints and duration of their use was not 
described.14 Four studies found that adults >58 or >60 years of age consumed 
less alcohol as compared to younger cohorts (204.1g/day vs. 288.3g/day, 
172g/day vs. 214g/day, 207g/day vs. 219g/day, and 16 drinks/day vs. 20.5 
drinks/day respectively) during the 30 days or the binge before presentation,10-
12,14 while one found no difference in alcohol consumption.13 
 
DISCUSSION 
     Despite knowledge that alcohol abuse disorders and, in particular, alcohol 
withdrawal syndrome are increasing in prevalence in the elderly, very little 
research has been done to explore this growing health concern. As a result, a 
consensus regarding clinical approaches to diagnosis and treatment has not 
been reached. When considering these studies together, it is clear that alcohol 
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use and abuse, as well as the sequelae of alcohol withdrawal syndrome 
represent significant clinical problems in older adults. However, given the 
small number of studies and the great variability in the methodologies used by 
each study, we have a limited ability to extract many meaningful conclusions 
to help begin to close our knowledge gap.   
Despite the numerous limitations of these studies, taken collectively, 
several preliminary insights about alcohol withdrawal in the elderly may be 
made that begin to better characterize this vulnerable population, the 
treatment they receive, and their hospital course. Two of the studies 
demonstrated that elderly patients being treated with benzodiazepines for 
alcohol withdrawal required equal cumulative doses and sometimes even 
higher and more frequent dosing as compared to their younger cohorts. 10,12-14 
This is particularly interesting for several reasons. First, this is contrary to what 
we might expect --- given well-studied examples of the reduction in drug 
metabolism in the elderly --- namely, that this group of patients would require 
much lower doses in order to achieve the same effects.16,17 However, this is 
not the case. Second, this finding goes against the current mantra in geriatric 
pharmacology of “start low and go slow”, and perhaps suggests that, in the 
setting of alcohol withdrawal, clinicians should consider treatment with the 
same doses of benzodiazepines as would be considered in younger 
patients.18,19 A potential explanation is the possible existence and effect of 
kindling in this clinical setting. Perhaps elderly patients with repeated episodes 
of alcohol withdrawal suffer progressively more severe episodes of withdrawal 
symptoms and thus require the need for higher than expected subsequent 
doses of benzodiazepines. 
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While it may not be surprising that hospitalized elderly patients may be 
at higher risks for the complications associated with alcohol withdrawal such 
as seizures, elevated blood pressure, hypokalemia, and dehydration, as 
compared with younger adults given their multiple co-morbidities and age-
related physiologic differences, it further emphasizes that elderly patients with 
alcohol withdrawal are at higher risk for hospital associated morbidity.  
Another notable finding is that of rates of delirium. While research has 
already shown that older adults are more susceptible to delirium in a variety of 
clinical settings and that numerous causes and precipitants are contributing 
factors in the development of delirium, the toxicologic emergency of alcohol 
withdrawal may place the elderly at an even higher risk for both the 
development and the severity of delirium.20-23 What can be concluded is that in 
older adults hospitalized with alcohol withdrawal syndrome, delirium is a 
serious complication. 
Despite being mentioned in only the 1997 study done by Kraemer, the 
use of restraints warrants comment. Kraemer noted that restraint use was 
significantly higher in older adults with alcohol withdrawal as compared to 
younger adults. Because recent research has shown that restraint use in the 
elderly is not appropriate should be used rarely, if at all, this study’s findings 
raise some questions.24,25 Future research might look more closely at rates of 
restraint use in elderly patients with alcohol withdrawal and, in particular, the 
situations in which they are used and the outcomes of their use.  
While kindling is a phenomenon associated mostly with benzodiazepine 
withdrawal, alcohol has a very similar mechanism of tolerance and withdrawal 
involving gamma-Aminobutyric acid (GABA) and N-methyl-D-aspartate 
(NMDA) receptors.26,27 Upon review of these studies, there may be occurring 
	  19	  
	  
some type of ‘kindling effect’ in elderly patients with chronic alcohol use or 
abuse that may partially be explained by their age-related changes in both 
pharmacokinetics and pharmacodynamics. Wojnar, Liskow, and Wetterling all 
demonstrated that elderly patients suffering from clinically significant alcohol 
withdrawal had in fact consumed less alcohol in the recent days surrounding 
the commencement of their withdrawal episode compared to younger cohorts, 
suggesting that their withdrawal occurred after deviating from lower baseline 
alcohol levels.10-12 This may be explained by kindling if the hypothesis holds 
true that this age group has had more years of alcohol abuse and subsequent 
episodes of detoxifications. 
Although some notable conclusions can be drawn from the limited 
amount of available research, it is clear that there are still many unanswered 
questions. Alcohol withdrawal in the elderly population remains a significantly 
under-recognized clinical entity and a grossly understudied phenomenon. 
While much more research needs to be done, some of the limitations 
concluded as a result of this systematic review must be addressed. 
Standardizing methodologies would be of critical importance. Adopting the 
currently accepted age definition for geriatrics of >65, employing standardized 
scales such as CIWA, since it has been validated in a number of settings both 
impatient and outpatient, and selecting similar outcomes to measure, such as 
length of stay, rates of delirium, frequency of electrolyte disturbances, dosing 
of benzodiazepines, and frequency of vital sign abnormalities, and would 
prove to be important so that groups could be more easily compared and 
analyzed so that subsequent conclusions may be made more accurately.  
Several future key topics warrant exploration and expansion. One 
important subject is the potential delay in the diagnosis of alcohol withdrawal. 
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A core concept in geriatric emergency medicine is that of atypical disease 
presentation. In older adults, common disease entities very frequently present 
atypically, such as altered mentation in sepsis, abdominal discomfort in acute 
myocardial infarction, and absence of cough in pneumonia to name a few.28 It 
seems plausible that the potential for atypical disease presentation in the 
elderly, coupled with aging physiology, poorer baseline cognitive function, and 
potential under-estimation or frank ignorance on the part of the clinician 
regarding alcohol consumption in the elderly, makes a delay in diagnosis very 
likely. If, in fact, delays in diagnosis do exist, what impact does this have on 
the management and outcomes of this patient population? This is yet another 
topic that might be helpful to focus on in this patient population when they 
present to the Emergency Department (ED). The ED is where the majority of 
these patients get admitted for alcohol withdrawal, and they do not always 
present clearly to the ED physician. Perhaps looking at the barriers in 
identifying these patients in the ED would be of importance in beginning to 
understand their atypical presentations and allowing us to better manage them 
from the initial stages of alcohol withdrawal. This may have the potential 
ultimately to decrease morbidity and mortality in this growing and vulnerable 
population. 
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ABSTRACT 
 
OBJECTIVE: To describe the population of older adults with alcohol 
withdrawal who present to the Emergency Department (ED) and are admitted 
to the hospital.  
 
DESIGN: Retrospective chart review 
 
METHODS: We conducted a retrospective chart review of patients aged ≥ 65 
years who presented to the ED and were admitted and treated for alcohol 
withdrawal syndrome (AWS). Potential patients were identified using ICD-9 
diagnosis codes for alcohol-induced mental disorders (291.0-291.89).  
Patients were excluded if no alcohol withdrawal treatment was administered or 
the subject was directly admitted to the psychiatry service. Data regarding 
demographics, symptoms, treatments, and outcomes were. Results were 
presented as proportions, means and standard deviations, and medians with 
interquartile ranges.   
 
RESULTS:  A total of 211 patients were screened and 90 were given a 
diagnosis of AWS and are included in this analysis. The mean age of the 
sample was 73 years and 59% were men. The most common physical 
comorbidity reported was hypertension (16%) and coronary artery disease 
(19%); 16% had multiple (≥ 3) major medical comorbidity. The chief complaint 
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was alcohol-related (48%), trauma (30%), followed by psychiatric conditions 
(13%); 13% were suicidal at presentation.  Tremors were documented in 42% 
of cases, and were present for 32% and not present for 10%.  Hyperreflexia 
was not documented in 99% of cases.  Tongue fasciculations were 
documented in 13% and were present in 10% and not present in 3%.  In total, 
59% received at least one dose of a benzodiazepine in the ED; specifically 
lorazepam (12%), diazepam (21%) or chlordizepoxide (4%); an additional 22% 
received a combination of these.  For 41%, no benzodiazepine was ordered in 
the ED.  The standard Clinical Institute Withdrawal Assessment protocol was 
followed in 41%.  The discharge destination was to home for 56%, to a 
monitored setting for 29%, and to a detoxification facility for 6%.  Based on 
post-discharge surveillance, 36 patients (25%) presented to the ED again 
within 30 days; of these 18 had alcohol-related conditions, 10 had trauma, 3 
had psychiatric conditions, and 14 had other diagnoses.   
 
CONCLUSION:  Our study demonstrates that commonly held notions that 
elderly patients with AWS are more likely to have multiple comorbidities, live 
alone, and present with a traumatic or infectious complaints, is not universally 
correct. Going forward, ED physicians likely need to reassess how they 
approach older adults, to raise their index of suspicion for alcohol withdrawal 
in this population, and to be more systematic and efficient in identifying older 
adults with AWS.  
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INTRODUCTION 
Excessive chronic alcohol consumption among older adults is a 
common but under-recognized entity. Alcohol withdrawal syndrome (AWS), 
which can occur when a chronic user abruptly stops alcohol intake, can be 
associated with severe and sometimes life threatening complications.  If AWS 
goes unrecognized and does not receive aggressive treatment early in its 
course, such as when a patient presents in the Emergency Department (ED), 
it can quickly progress to complications such as seizures, delirium tremens, 
autonomic instability, and even death.9  
Currently there is little information about AWS in older adults; most 
information pertains to younger patients. While features of AWS in younger 
patients potentially could be extrapolated to older patients, aspects of the 
syndrome may be unique to older adults.  For example, there may be 
physiologic differences between the age groups that influence presentation 
and subsequent clinical course.28  These may include well-known aspects of 
health in older adults, such as less physiologic reserve, more medical 
comorbidity, altered pharmacokinetics, increased central nervous system 
sensitivity to toxins, underlying cognitive deficits, and greater susceptibility to 
medication-alcohol interactions.17,28  
A better understanding of AWS in older adults is critical to improve its 
early recognition in the ED and tailor its treatment in order to optimize care for 
these particularly vulnerable patients.  The goal of this study was to describe a 
sample of older adults admitted with alcohol withdrawal at our academic 
medical center in an attempt to better characterize these patients as they 
presented to the ED.  
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METHODS 
We conducted a retrospective chart review of patients aged ≥ 65 years 
who presented to the ED and were admitted and treated for alcohol withdrawal 
at a large, urban, academic medical center from 1/1/08 – 3/31/12.  Potential 
patients were identified using ICD-9 diagnosis codes for alcohol-induced 
mental disorders (291.0-291.89).  Patients were excluded if no alcohol 
withdrawal treatment was administered or the subject was directly admitted to 
the psychiatry service. 
We comprehensively reviewed the ED and hospital charts of each 
patient and each admission (including multiple admissions for patients with 
repeated visits) to collect information about demographics, vital signs, 
medication orders, laboratory test results, and treatments received in the ED 
and hospital as documented by ED staff and in-patient physicians, nurses, 
psychiatrists, physical therapists, and social workers.  Data were abstracted 
from the medical records systematically using a standardized data abstraction 
protocol we developed before beginning chart review. This protocol included 
hierarchies of data sources for each data point to resolve any internal 
inconsistencies within the medical record.  For example, for marital status, the 
social worker’s documentation was considered most accurate.  If the social 
worker’s documentation was not available or did not include this information, 
we would record, in order, information from a psychiatry consultant, the 
admitting physician, and administrative records.   Developing this protocol was 
critical because we encountered frequent internal inconsistencies within the 
medical record.  This situation was anticipated as it is commonly encountered 
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when conducting research with chronic substance users who may not divulge 
information or be truthful with health care personnel.   
Data were entered into a customized, secure, online, HIPPA compliant, 
REDCap database.  Data analysis was conducted using STATA v12.0 (Stata 
Corp, College Station, TX).  Results are presented as proportions, means and 
standard deviations, and medians with interquartile ranges.   
This study was approved by the Weill Cornell Medical College 
Institutional Review Board. 
 
RESULTS 
 To total, 211 patients were screened and 90 were given a diagnosis of 
AWS and are included in this analysis.  The mean age of the sample was 73 
years and 59% were men (Table 2.1).  Approximately one quarter were 
currently married and most (61%) lived alone; 7% were undomiciled.   Most 
patients did not report illicit drug use and most reported being current (32%) or 
former (30%) smokers.   
 The most common physical comorbidity reported was hypertension 
(16%) and coronary artery disease (19%); 16% had multiple (≥ 3) major 
medical comorbidity (Table 2.2).  The prevalence of mental health comorbidity, 
however, was higher (35%), with the most common conditions being 
depression (23%) and anxiety (10%).  Approximately one quarter reported 
taking prescribed out-patient opioids or benzodiazepines.   The vast majority 
of patients (91%) reported a history of alcohol use/abuse and 15% reported 
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previous treatment in a detoxification facility.   Approximately one quarter 
reported being treated for alcohol withdrawal in the past; symptoms included 
seizures (16%) and delirium tremens (10%).   
These 90 patients had a total of 145 visits to the ED for AWS during the 
study period (18 patients had multiple visits, specifically 72 had 1 visit, 16 had 
2 visits, 2 had ≥ 3 visits). For the majority of visits patients presented to the ED 
by ambulance (74%) and were not accompanied by family or an aide (63%) 
(Table 2.3).  The chief complaint was alcohol-related (48%), trauma (30%), 
followed by psychiatric conditions (13%); 13% were suicidal at presentation.   
With respect to vital signs potentially associated with withdrawal, at triage 40% 
of cases had a heart rate ≥ 100 beats per minute and 32% had a systolic 
blood pressure ≥ 160 mmHg or a diastolic blood pressure ≥ 100 mmHg; 14% 
had both tachycardia and elevated blood pressure.  31% of cases were 
considered intoxicated on arrival; however, this information was not 
documented for 34%.   
ED physical examination records were reviewed for specific features 
associated with withdrawal, such as tremors, hyperreflexia, and tongue 
fasiculations.   Tremors were documented in 42% of cases, and were present 
for 32% and not present for 10% (Table 2.4).  Hyperreflexia was not 
documented in 99% of cases.  Tongue fasciculations were documented in 
13% and were present in 10% and not present in in 3%.  A blood alcohol level 
was ordered for 61%. In total, 59% received at least one dose of a 
benzodiazepine in the ED; specifically Lorazepam (12%), Diazepam (21%) or 
Chlordizepoxide (4%); an additional 22% received a combination of these.  For 
41%, no benzodiazepine was ordered in the ED.   
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All patients were admitted to the hospital, either to a regular floor (66%), 
a step-down unit (19%), or an intensive care unit (6%); 3% were admitted and 
discharged from the ED before receiving an inpatient bed assignment (Table 
2.5).  A total of 93% received benzodiazepines and standard Clinical Institute 
Withdrawal Assessment (CIWA) protocol was followed in 41%.  The CIWA is a 
10-item scale that assesses nausea/vomiting, tremor, paroxysmal sweats, 
anxiety, agitation, headache, orientation, clouded sensorium, and tactile, 
auditory, and visual disturbances.   A social worker and psychiatric 
consultation was obtained for 52% and 23%, respectively.  The median length 
of stay was 6 days; and in several cases (9) left against medical advice after a 
median of 2 days.   
Two patients died during the hospitalization (respiratory failure and 
ventricular fibrillation cardiac arrest).  The discharge destination was to home 
for 56%, to a monitored setting (i.e. nursing home, acute/subacute facility) for 
29%, and to a detoxification facility for 6%.   Most patients were referred for 
additional medical care, including Alcoholics Anonymous (75%), but fewer 
were referred for psychiatric follow-up (17%).  Based on post-discharge 
surveillance of ED records, 36 patients (25%) presented to the ED again within 
30 days; of these 18 had alcohol-related conditions, 10 had trauma, 3 had 
psychiatric conditions, and 14 had other diagnoses.   
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Table	  2.1:	  Demographics,	  Social	  Characteristics	  &	  Reported	  Illicit	  Substance	  Use	  among	  
Patients	  Age	  ≥65	  Admitted	  from	  the	  Emergency	  Department	  for	  Treatment	  of	  Alcohol	  
Withdrawal,	  Jan	  2008-­‐Mar	  2012	  
	  
	  	   N	  =	  90	  patients	  
Age,	  years	  (mean	  ±	  SD)	  
73	  ±	  6	  
Range:	  65	  –	  89	  
Male	   53	  (59%)	  
	   	  Marital	  Status	  
	  
Single	   49	  (54%)	  
Married	   23	  (26%)	  
Divorced	   7	  (8%)	  
Widowed	   11	  (12%)	  
	   	  Living	  Situation	  
	  
Alone	   55	  (61%)	  
With	  spouse	   19	  (21%)	  
With	  Family	   5	  (6%)	  
With	  Friend(s)	   2	  (2%)	  
Nursing	  Home	   1	  (1%)	  
Undomiciled	   6	  (7%)	  
Other	   2	  (2%)	  
Not	  Documented	  	   -­‐-­‐	  
	   	  Smoking	  Status	  
	  
Never	   23	  (26%)	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Former	   27	  (30%)	  
Current	   29	  (32%)	  
Not	  Documented	   11	  (12%)	  
	   	  Illicit	  Drug	  Use	  
	  
Past	   8	  (9%)	  
Current	  (n=8)	   2	  (25%)	  
	  
Results	  presented	  as	  n	  (%)	  unless	  otherwise	  specified.	  For	  individuals	  with	  more	  than	  one	  
visit	  during	  the	  study	  period,	  results	  are	  presented	  for	  the	  first	  visit	  during	  the	  study	  period.	  	  
	  
SD	  denotes	  standard	  deviation.	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Table	  2.2:	  Medical,	  Psychiatric	  &	  Alcohol	  Use	  History	  among	  Patients	  Age	  ≥65	  Admitted	  from	  
the	  Emergency	  Department	  for	  Treatment	  of	  Alcohol	  Withdrawal,	  Jan	  2008-­‐Mar	  2012	  
	  
	  	   N	  =	  90	  patients	  
Medical	  Comorbidities	  (n=88)	  
	  
Cardiovascular	  
	  
Hypertension	   51	  (58%)	  
Coronary	  Artery	  Disease	   17	  (19%)	  
Atrial	  Fibrillation	   5	  (6%)	  
	   	  Liver	  
	  
Hepatitis	  B/C	   3	  (3%)	  
Cirrhosis	   2	  (2%)	  
	   	  Gastrointestinal	  	  
	  
Chronic	  Pancreatitis	   2	  (2%)	  
Peptic	  Ulcer	  Disease	   5	  (6%)	  
	   	  Neurologic	  
	  
Dementia	   5	  (6%)	  
Seizure	   1	  (1%)	  
CVA	  	   3	  (3%)	  
	   	  Anemia	   1	  (1%)	  
	   	  COPD/	  Asthma	   8	  (10%)	  
	   	  Diabetes	   11	  (13%)	  
	   	  3+	  comorbidities	   14	  (16%)	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Any	  PMH	  psychiatric	  conditions	  (n=89)	   31	  (35%)	  
Depression	   21	  (23%)	  
Anxiety	   9	  (10%)	  
Bipolar	   4	  (4%)	  
PTSD	   1	  (1%)	  
Schizophrenia	   0	  (0%)	  
Other	  Behavioral	  Health	   6	  (7%)	  
	   	  Medications	  Taken	  at	  Home	  
	  
Opioids	  (n=86)	   6	  (7%)	  
Benzodiazepine	  (n=85)	   14	  (16%)	  
	   	  Alcohol	  History	  
	  
Alcohol	  use/abuse	  listed	  in	  medical	  record	  	   81	  (91%)	  
Weekly	  quantity	  of	  alcohol	  normally	  	  
consumed,	  (number	  of	  drinks)	  median	  (IQR)	  
42	  (21	  –	  79)	  
Previous	  treatment	  in	  detox	  facility	   13	  (15%)	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Table	  2.2:	  (continued)	  
	  
Withdrawal	  History	  
	  
Alcohol	  withdrawal	  listed	  in	  medical	  record	   20	  (23%)	  
Treated	  for	  alcohol	  withdrawal	  in	  past	   23	  (26%)	  
Previous	  seizures	  with	  alcohol	  	  
withdrawal	  
14	  (16%)	  
Hallucinations	  with	  alcohol	  withdrawal	   2	  (1%)	  
Previous	  ICU	  for	  alcohol	  withdrawal	   1	  (1%)	  
Previous	  Delirium	  Tremens	   9	  (10%)	  
	   	  Admitted	  multiple	  times	  for	  withdrawal	  during	  study	  period	   18	  (20%)	  
	  
Results	  presented	  as	  n	  (%)	  unless	  otherwise	  specified.	  For	  individuals	  with	  more	  than	  one	  
visit	  during	  the	  study	  period,	  results	  are	  presented	  for	  the	  first	  visit	  during	  the	  study	  period.	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Table	  2.3:	  Characteristics	  of	  Emergency	  Department	  Presentation	  among	  Patients	  Age	  ≥65	  
Admitted	  from	  the	  Emergency	  Department	  for	  Treatment	  of	  Alcohol	  Withdrawal,	  Jan	  2008-­‐
Mar	  2012	  
	  
	  	   	  	  	  	  	  	  	  	  N	  =	  145	  cases	  
Means	  of	  arrival	  
	  
Walk-­‐in	  	   28	  (19%)	  
Ambulance	   106	  (74%)	  
Other	   5	  (3%)	  
Not	  documented	   6	  (3%)	  
	  
	  
Accompanied	  to	  the	  ED	  
	  
Alone	   90	  (63%)	  
Family	   16	  (11%)	  
Home	  health	  aide	  /	  nurse	   3	  (2%)	  
Other	   4	  (3%)	  
Not	  Documented	   32	  (22%)	  
	  
	  
Chief	  Complaint	  in	  ED	  Triage	  
	  
Alcohol	  related	   69	  (48%)	  
Trauma	  related	   43	  (30%)	  
Psychiatric	   19	  (13%)	  
Other	  complaint	  
	  
	   	  
Currently	  suicidal	  (n=124)	   16	  (13%)	  
	  40	  
	  
Currently	  homicidal	  (n=124)	   0	  (0%)	  
	  
	  
Vital	  Sign	  Abnormalities	  in	  Triage	  
	  
Heart	  rate	  ≥100	   57	  (40%)	  
Blood	  pressure	  (SBP	  ≥160	  or	  DBP	  ≥100)	   46	  (32%)	  
Both	  elevated	  heart	  rate	  and	  blood	  pressure	  
during	  ED	  evaluation	  (HR	  >100	  and	  	  
(SBP	  ≥160	  or	  DBP	  ≥100))	  
21	  (14%)	  
	  
	  
Recognized	  as	  intoxicated	  at	  arrival	  (n=143)	  
	  
No	   50	  (35%)	  
Yes	   44	  (31%)	  
Not	  documented	   49	  (34%)	  
	  
Results	  presented	  as	  n	  (%)	  unless	  otherwise	  specified.	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Table	  2.4:	  ED	  Assessment	  &	  Treatment	  among	  Patients	  Age	  ≥65	  Admitted	  from	  the	  
Emergency	  Department	  for	  Treatment	  of	  Alcohol	  Withdrawal,	  Jan	  2008-­‐Mar	  2012	  
	  
	  	   N	  =	  145	  cases	  
Signs	  of	  Withdrawal	  Documented	  in	  ED	  attending	  examination	   	  
Tremor	  (n=143)	   	  
Documented	  and	  Present	   46	  (32%)	  
Documented	  and	  Not	  Present	   14	  (10%)	  
Not	  Documented	   83	  (58%)	  
Hyperreflexia	  (n=144)	   	  
Documented	  and	  Present	   1	  (1%)	  
Documented	  and	  Not	  Present	   1	  (1%)	  
Not	  Documented	   142	  (99%)	  
Tongue	  fasciculations	  (n=144)	   	  
Documented	  and	  Present	   15	  (10%)	  
Documented	  and	  Not	  Present	   5	  (3%)	  
Not	  Documented	   124	  (86%)	  
	   	  
No	  documentation	  of	  assessment	  for	  withdrawal	  (tremor,	  
hyperreflexia,	  or	  tongue	  fasciculations)	  
60	  (41%)	  
	   	  
Vital	  Sign	  Abnormality	  during	  ED	  evaluation	   	  
Heart	  rate	  recorded	  >100	   83	  (58%)	  
Blood	  pressure	  recorded	  (SBP	  ≥160	  or	  DBP	  ≥100)	   62	  (43%)	  
Both	  heart	  rate	  and	  blood	  pressure	   42	  (29%)	  
	  42	  
	  
During	  ED	  evaluation	  (HR	  >100	  and	  	  
(SBP	  ≥160	  or	  DBP	  ≥100))	  
	   	  Blood	  Alcohol	  Level	  	  
	  
Ordered	   87	  (61%)	  
Level	  of	  positive	  results	  (mg/dL),	  median	  (IQR)	  
208	  (103	  –	  265)	  
Range:	  5	  –	  449	  
Negative	   33	  (39%)	  
	   	  First	  Benzodiazepine	  ordered	  in	  ED	   	  
Lorazepam	   34	  (23%)	  
Diazepam	   40	  (27%)	  
Chlordiazepoxide	   18	  (12%)	  
	   	  
Benzodiazepine	  ordered	  in	  ED	  
	  
Lorazepam	  Only	   17	  (12%)	  
Diazepam	  Only	   31	  (21%)	  
Chlordiazepoxide	  Only	   6	  (4%)	  
Multiple	   32	  (22%)	  
None	   59	  (41%)	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Table	  2.4:	  (continued)	  
	  
%	  of	  Patients	  with	  ED	  Diagnosis	  	  
	  
Alcohol	  Related	   101	  (70%)	  
Trauma	   33	  (23%)	  
Psychiatric	   5	  (3%)	  
Other	   63	  (43%)	  
	  
Results	  presented	  as	  n	  (%)	  unless	  otherwise	  specified.	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Table	  2.5:	  Hospital	  Admission	  &	  Treatment	  among	  Patients	  Age	  ≥65	  Admitted	  from	  the	  
Emergency	  Department	  for	  Treatment	  of	  Alcohol	  Withdrawal,	  Jan	  2008-­‐Mar	  2012	  
	  
	  	   N	  =	  145	  cases	  
Admitting	  Service	  
	  
Regular	  floor	   95	  (66%)	  
Step-­‐down	   27	  (19%)	  
ICU	   9	  (6%)	  
Discharged	  directly	  from	  ED	   4	  (3%)	  
Other/not	  documented	   10	  (7%)	  
	   	  Benzodiazepine	  given	  during	  admission	  
	  
Lorazepam	  Only	   38	  (26%)	  
Diazepam	  Only	   10	  (7%)	  
Chlordiazepoxide	  Only	   4	  (3%)	  
Other	   1	  (1%)	  
Multiple	   82	  (57%)	  
None	   10	  (7%)	  
	   	  Alcohol	  withdrawal	  protocol	  followed	  
	  
CIWA*	  score	  calculated	   58	  (41%)	  
	   	  Consultations	  obtained	  during	  admission	  
	  
Trauma	   1	  (1%)	  
Psychiatry	   34	  (23%)	  
Social	  Work	   75	  (52%)	  
	   	  Length	  of	  Stay	  (days)	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Overall,	  median	  (IQR)	   6	  (4	  –	  10)	  
Discharged,	  median	  (IQR)	   6	  (4	  –	  11)	  
AMA,	  median	  (IQR)	   2 (1 – 3) 
	  
Results	  presented	  as	  n	  (%)	  unless	  otherwise	  specified.	  
‘*’	  Clinical	  Institute	  Withdrawal	  Assessment,	  possible	  range	  0-­‐67;	  withdrawal	  mild	  (≤15),	  
moderate	  (16-­‐20),	  severe	  (>20).	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Table	  2.6:	  Hospital	  Discharge	  &	  Readmission	  among	  Patients	  Age	  ≥65	  Admitted	  from	  the	  
Emergency	  Department	  for	  Treatment	  of	  Alcohol	  Withdrawal,	  Jan	  2008-­‐Mar	  2012	  
	  
	  	   N	  =	  145	  cases	  
Discharge	  
	  
Home	   80	  (56%)	  
Nursing	  Home	   11	  (8%)	  
Acute	  Care	  Facility	   4	  (3%)	  
Subacute	  Care	  Facility	   25	  (17%)	  
Detox	  Facility/	  Program	  	   9	  (6%)	  
AMA	   9	  (6%)	  
Death	   2	  (1%)	  
Other	   3	  (2%)	  
Not	  Documented	   1	  (1%)	  
	   	  Referrals	  in	  Discharge	  Note	  
	  
Alcoholics	  Anonymous	   109	  (76%)	  
Psychiatric	  Follow-­‐up	   23	  (17%)	  
Primary	  Care	  Follow-­‐up	   108	  (78%)	  
Specific	  Appointment	  in	  Note	   44	  (32%)	  
	   	  
Re-­‐presentation	  to	  the	  ED	  within	  30	  Days	  
	  
Any	  Reason	   36	  (25%)	  
	   	  
Second	  presentation	  ED	  diagnosis	  
	  
Alcohol	  Related	   18	  (50%)	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Trauma	   10	  (28%)	  
Psychiatric	   3	  (8%)	  
Other	   14	  (39%)	  
	  
Results	  presented	  as	  n	  (%)	  unless	  otherwise	  specified.	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DISCUSSION 
 The results of our study demonstrate that alcohol withdrawal is not 
restricted to younger adults, but also occurs in the elderly with sufficient 
severity that some patients require hospital admission and formal 
detoxification management.  Further, a large proportion of patients re-present 
to the ED with both alcohol-related and other conditions within only 30 days.   
Our study also demonstrates that evaluations for AWS in the elderly are not 
uniformly done and protocols may be needed to systematically evaluate and 
treat these patients while in the ED.  In addition to increasing awareness that 
AWS is a potential diagnosis in the elderly (and not prevalent only in younger 
adults), our study highlights the importance of timely interventions that should 
be priorities in the ED management of these patients.    
Few other studies have considered AWS in the elderly.  Our review of 
the literature over the last 3.5 decades found only 7 studies that addressed 
AWS in older adults.9-15 However, these studies differed markedly in design, 
setting, and age inclusion criteria.  As a result, little information could be 
extracted and complied in any systematic way; thus no conclusions about 
presentation and optimal management can be made.  In order to begin to 
understand how to assess and treat older adults with AWS more effectively, a 
better characterization of this population is needed.  Specifically, information is 
required to assist medical providers, particularly ED physicians, in identify 
these patients more readily upon presentation.  In addition, analyzing their 
management in the ED and on the inpatient hospital service, as well as 
ascertaining their final disposition, is crucial towards the goal of optimizing 
their care.   
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Our study also showed that AWS occurs in a broad spectrum of older 
patients, including women, who traditionally are considered less likely to 
present to the ED for alcohol abuse.29  It was also surprising to find that the 
majority of patients reported no illicit drug use. While this is based on self-
report, it still warrants some thought, considering the high rates of concurrent 
drug and alcohol abuse in younger populations.30 It is possible that elderly 
patients are more likely to abuse only alcohol.  However, possible co-
substance abuse should remain a concern and be investigated further in 
elderly AWS patients.  
Several of our findings regarding comorbidity also are noteworthy.  In 
particular, the prevalence of self-reported physical comorbidity was lower than 
expected.  Perhaps this can be explained by insufficient primary care and 
continuity of care often found in patients with alcohol abuse, and thus lack of 
awareness and treatment for other diagnoses.  This further highlights the need 
for clinicians to be more vigilant about possible occult diseases in elderly 
patients who do not report comorbidity.  It also may be a marker for poor follow 
up secondary to alcohol abuse or some other substance abuse.   These 
issues are important to consider particularly for conditions that are 
exacerbated by alcoholism, such as hypertension, coronary artery disease, 
liver disease, obesity, and diabetes.31-33,34  With respect to mental health 
comorbidity, our findings are consistent with other reports documenting a high 
prevalence of concurrent psychiatric illness in patients admitted for AWS.30 
Also similar to other reports, we found that although 91% of our patients 
reported a history of alcohol use or abuse, only 15% had been previously 
admitted to a treatment facility.  Non-participation in formal detoxification and 
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rehabilitation programs, irrespective of age, has been attributed to lack of 
access or lack of interest in stopping alcohol use.  
Our study highlights additional considerations in the comprehensive 
evaluation of elderly AWS patients.  One major issue is reliance on self-report 
and the lack of confirming information.  In order to manage patients optimally, 
information about the events that prompted the ED visit is critical.  However, in 
our study only 16% were accompanied to the ED by another adult.  Relying on 
self-report assumes the patient is able to provide a full and concise history on 
his or her own.  Ideally, additional sources of information should be sought 
whenever possible to ascertain what is cause and what is effect.  For example, 
in our study, the chief complaint was trauma-related in 30% and psychiatric-
related in 13%.  Thus, it is of paramount importance that ED physicians screen 
elderly patients presenting with falls or other traumas, as well as those with 
psychiatric complaints, for alcohol abuse because it may be either the 
precipitating factor or a contributing factor for the etiology of their chief 
complaint.    
Because a rigorous history may be lacking in elderly AWS patients, the 
role of the physical examination becomes critical.  It was noteworthy that in our 
study few patients presented with both elevated blood pressures and 
tachycardia; unlike the typical dyad in younger adults with AWS.  It is well 
known that, in general, older individuals are much less likely than younger 
individuals to mount an appropriate response to stressful situations because of 
either blunted age-related change in physiologic response and/or effects of 
baseline medications.17,28   It is very likely that this can be extrapolated to 
AWS, in which case relying on traditional vital sign derangements, as markers 
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for AWS may not be appropriate in older patients.   Additional research is 
needed to investigate this phenomenon further.   
 Our study also supports the need for a comprehensive physical 
examination and a standard ED protocol for evaluation and management of 
possible AWS in the elderly.  This is so because ED physicians do not 
routinely consider alcohol use or withdrawal in older adults and subsequently 
may not do a physical examination targeted at withdrawal, such as assess for 
tongue fasciculations, which have been shown to be early indicators of alcohol 
withdrawal.9,35 However, as noted above, which elements of the physical 
examination are most sensitive to AWS in the elderly have not been 
determined and should be investigated further.   This certainly also is the case 
for the management of the elderly AWS patient.  In our study, less than half of 
patients received benzodiazepines, the mainstay of treatment, while in the ED.  
On the other hand, almost a quarter received more than one benzodiazepine, 
which runs counter to well-studied guidelines for pharmacotherapy in older 
adults.36 While providers may have been attempting to take advantage of the 
different onsets of action and half-lives, potential development of delirium is 
strongly increased by this approach.  Future investigation into differences in 
outcomes in patients receiving one versus more than one benzodiazepine is 
necessary. 
Our study also addressed the subsequent post-ED management of 
elderly AWS patients.   The rate of admission to either an intensive care unit or 
a step-down unit was higher than what has been reported for younger adults.37 
This also was the case for the average length of stay.9 This suggests that 
older adults are more likely to have a complicated in-patient course.  However, 
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despite a more complex clinical scenario and the fact that alcohol dependence 
is classified as a DSM-V disorder and is associated with comorbid psychiatric 
conditions, most patients did not receive psychiatric consults during their 
admission. 30 Other studies have advocated that psychiatric consultation 
should be a mainstay for patients admitted with AWS.38 This finding, along 
with the low referral rate to outpatient psychiatric follow-up, again reinforces a 
common theme in our study; namely, that clinicians do not approach older 
adults with alcohol abuse disorder and AWS the same way as they might with 
younger patients.  
There are several limitations to our study.  First, it was conducted in a 
tertiary care medical center and may not be generalizable to patients in other 
settings.   Second, it was based on retrospective chart review and certain 
clinical aspects, such as physical examination, may have been done, but were 
not recorded.  Third, we did not include patients admitted to the psychiatric 
service; these individuals most likely represent a subset of AWS that has 
different characteristics and management needs.     
 In summary, our study demonstrates that commonly held notions that 
elderly patients with AWS are more likely to have multiple comorbidities, live 
alone, and present with a traumatic or infectious complaints, is not universally 
correct.  After describing an elderly population at our institution with a 
diagnosis of AWS, we see that, apart from living alone, the majority of patients 
did not have multiple comorbidities and most did not present with either 
trauma or infection.  Perhaps ED physicians need to re-assess how they 
approach older adults, to raise their index of suspicion for alcohol withdrawal 
in this population, and to be more systematic and efficient in identifying older 
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adults with AWS.  The overarching goals are to make the diagnosis of AWS as 
soon as possible and institute necessary therapy early in the patient’s course 
while still in the ED.   
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